Update: Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment-resistant Epilepsy
Practice Guideline, June 2018
Read Published ArticleSince the 2004 publications, the US Food and Drug Administration (FDA) approved 6 new third-generation AEDs and 2 older AEDs. This update reviews new evidence for efficacy of these AEDs in managing treatment-resistant (TR) focal epilepsies and generalized epilepsies (GEs) in children and adults.
Reaffirmed on September 18, 2021.
Codeveloped with the American Epilepsy Society.
Clinician Tools and Materials
Clinician Summary
Download a PDF summary of this guideline product
Educational Materials
Other resources related to this guideline
Guideline Translations
Read guidelines in alternative languages
Patient Tools and Materials
Patient Summary
Read a summary of the key messages of this guideline product for patients and care partners.